Christine Mikail Cvijic

Companies

• Neurogene Inc.Board member May 8, 2026 to now¹
• Neurogene Inc.Chief financial officer Dec 26, 2023 to now²
• Neurogene Inc.President Dec 26, 2023 to now²
• Sio Gene Therapies Inc.Chief Admin Officer and GC Jun 10, 2015 to May 3, 2016³
• NPS Pharmaceuticals (United States)SVP, Legal Affairs & GC Mar 7, 2014 to Feb 24, 2015⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• NNeurogene Inc. NGNE84,040 shares⁵$2.0M at $23.89Jul 7, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 7, 2026Sold 4,200 shares at $36.13 of Neurogene Inc.⁵
• Jul 6, 2026Sold 600 shares at $36.02 of Neurogene Inc.⁵
• Jul 2, 2026Sold 1,530 shares at $35.23 of Neurogene Inc.⁶
• Jul 2, 2026Sold 2,531 shares at $34.58 of Neurogene Inc.⁶
• Jul 1, 2026Sold 739 shares at $34.06 of Neurogene Inc.⁶
• May 6, 2026Sold 4,800 shares at $32.44 of Neurogene Inc.⁷
• May 6, 2026Sold 4,800 shares at $30.07 of Neurogene Inc.⁷
• Mar 26, 2026Sold 2,558 shares at $21.62 of Neurogene Inc.⁸
• Mar 13, 2026Sold 263 shares at $22.02 of Neurogene Inc.⁹
• Mar 13, 2026Sold 1,395 shares at $21.25 of Neurogene Inc.⁹
• Mar 13, 2026Sold 2,387 shares at $20.42 of Neurogene Inc.⁹
• Feb 27, 2026Sold 4,800 shares at $25.11 of Neurogene Inc.¹⁰
• Feb 20, 2026Granted 22,000 shares of Neurogene Inc.¹¹
• Mar 26, 2025Granted 20,300 shares of Neurogene Inc.¹²
• Mar 13, 2025Sold 4,501 shares at $16.94 of Neurogene Inc.¹³
• Nov 22, 2024Bought 24,000 shares at $20.48 of Neurogene Inc.¹⁴
• Mar 13, 2024Granted 31,903 shares of Neurogene Inc.¹⁵